Role of increased production of monocytes TNF-α, IL-1β and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments-Reference-Cited by-同舟云学术

Role of increased production of monocytes TNF-α, IL-1β and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments

Published:1997-02 Issue:2 Volume:14 Page:145-153
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Mizutani Hitoshi,Ohmoto Yasukazu,Mizutani Tomoko,Murata Minoru,Shimizu Masayuki

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference20 articles.

1. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis;Groves;Am J Pathol,1994

3. Interleukin-1 in human skin: dysregulation in psoriasis;Cooper;J Invest Dermatol,1990

4. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta;Cooper;J Immunol,1990

5. Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids;Gruaz;Dermatologica,1989

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Coffee Cherry Pulp Extract against Polycyclic Aromatic Hydrocarbons in Air Pollution Induced Inflammation and Oxidative Stress for Topical Applications;International Journal of Molecular Sciences;2024-08-30

2. Cytokines in psoriasis: From pathogenesis to targeted therapy;Human Immunology;2024-07

3. Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies;International Journal of Nanomedicine;2024-02

4. A Study Correlation between Levels IL-15, IL-23 and TNF-α in a Sample of Iraqi Psoriasis Patients;Ibn AL-Haitham Journal For Pure and Applied Sciences;2024-01-20

5. Investigational monoclonal antibodies in early development for psoriatic arthritis: beyond the biosimilars;Expert Opinion on Investigational Drugs;2023-08-03